122 related articles for article (PubMed ID: 7813558)
1. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis.
Rudd JA; Jordan CC; Naylor RJ
Eur J Pharmacol; 1994 Sep; 262(1-2):R1-2. PubMed ID: 7813558
[TBL] [Abstract][Full Text] [Related]
2. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.
Rudd JA; Naylor RJ
Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616
[TBL] [Abstract][Full Text] [Related]
3. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Kan KK; Ngan MP; Rudd JA; Yeung JH
Eur J Pharmacol; 2003 Apr; 466(1-2):163-8. PubMed ID: 12679153
[TBL] [Abstract][Full Text] [Related]
4. Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Chan SW; Rudd JA; Yeung JH
Eur J Pharmacol; 2001 Apr; 417(3):231-7. PubMed ID: 11334855
[TBL] [Abstract][Full Text] [Related]
5. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
[TBL] [Abstract][Full Text] [Related]
6. Using telemetry to automate the detection of emesis in the ferret: new vistas for delayed emesis assessment.
Goineau S; Rompion S; Guillaume P; Barrais L; Castagné V
J Pharmacol Toxicol Methods; 2013; 68(1):160-5. PubMed ID: 23578691
[TBL] [Abstract][Full Text] [Related]
7. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
[TBL] [Abstract][Full Text] [Related]
8. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets.
Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ
Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886
[TBL] [Abstract][Full Text] [Related]
9. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
Rudd JA; Jordan CC; Naylor RJ
Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced emesis in the Ferret: a new animal model.
Florczyk AP; Schurig JE; Bradner WT
Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
[TBL] [Abstract][Full Text] [Related]
11. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
[TBL] [Abstract][Full Text] [Related]
12. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
[TBL] [Abstract][Full Text] [Related]
13. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Ngan MP; Riendeau D; Robichaud A; Rudd JA
J Pharmacol Sci; 2007 Feb; 103(2):189-200. PubMed ID: 17310074
[TBL] [Abstract][Full Text] [Related]
14. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret.
Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG
Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305
[TBL] [Abstract][Full Text] [Related]
15. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
Goineau S; Guillaume P; Barrais L; Castagné V
Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
[TBL] [Abstract][Full Text] [Related]
16. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.
Costall B; Domeney AM; Naylor RJ; Tattersall FD
Neuropharmacology; 1987 Sep; 26(9):1321-6. PubMed ID: 2890117
[TBL] [Abstract][Full Text] [Related]
17. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.
Hawthorn J; Ostler KJ; Andrews PL
Q J Exp Physiol; 1988 Jan; 73(1):7-21. PubMed ID: 3347698
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three preclinical models for nausea and vomiting assessment.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
[TBL] [Abstract][Full Text] [Related]
19. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
20. Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret.
Endo T; Minami M; Monma Y; Saito H; Takeuchi M
J Toxicol Sci; 1990 Nov; 15(4):235-44. PubMed ID: 1707101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
